FAMILIAL CHYLOMICRONEMIA
Clinical trials for FAMILIAL CHYLOMICRONEMIA explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL CHYLOMICRONEMIA trials appear
Sign up with your email to follow new studies for FAMILIAL CHYLOMICRONEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could tame rare 'Fat Blood' disease and prevent pancreatitis
Disease control CompletedThis Phase 3 study tested a drug called plozasiran (ARO-APOC3) in 75 adults with familial chylomicronemia syndrome, a rare genetic disorder causing extremely high blood fat levels and risk of pancreatitis. Participants received four injections of the drug or a placebo over severa…
Matched conditions: FAMILIAL CHYLOMICRONEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug targets dangerous fat levels in blood
Disease control CompletedThis early-stage study tested a new medicine called ARO-APOC3 in healthy volunteers and people with severely high triglycerides or a rare genetic condition called familial chylomicronemia syndrome. The main goal was to check safety and how the drug moves through the body. The stu…
Matched conditions: FAMILIAL CHYLOMICRONEMIA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC